COMP <GO>
MMSI vs MMED // ALTMAN Z-SCORE & DEBT/EQUITY
Merit Medical Systems Inc. (NASDAQ) VS. MiniMed Group Inc. (NASDAQ) • 15-METRIC TALLY: MMSI 6
— MMED 6
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: MMED
LAST: $84.31 (-2.24%) • MKT CAP: $5.17B
balance-sheet
4.62
LAST: $18.90 (+3.39%) • MKT CAP: $5.14B
balance-sheet
4.82
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MMSI VS. MMED)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MMSI | MMED | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 48.70% | 54.20% | -5.50 | MMED | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 7.80% | -3.90% | +11.70 | MMSI | /roic <GO> |
| EV/EBITDA & P/E Valuation | 23.1x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 3.87% | -7.75% | +11.62 | MMSI | /fcf-yield <GO> |
| Operating Margin | 12.20% | -6.10% | +18.30 | MMSI | /operating-margins <GO> |
| Net Profit Margin | 8.50% | -10.70% | +19.20 | MMSI | /net-margins <GO> |
| Revenue Growth (YoY) | 11.80% | 14.30% | -2.50 | MMED | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 4.62 | 4.82 | -0.20 | MMED | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 5/9 | +4.00 | MMSI | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 43.5 | 44.5 | -1.00 | MMED | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.94 | 1.05 | -0.11 | MMED | /macro-sensitivity <GO> |
| Forward P/E Multiple | 40.4x | 24.0x | +16.40 | MMED | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.17B | $5.14B | $24.0M | MMSI | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MMSI REV | MMED REV | MMSI GROSS % | MMED GROSS % | MMSI FCF | MMED FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.52B | $3.10B | 48.7% | 54.2% | $215.7M | -$420.0M |
| FY 2024 | $1.36B | $2.71B | 47.4% | 56.3% | $185.7M | -$53.0M |
| FY 2023 | $1.26B | $2.47B | — | — | $88.6M | -$70.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MMSI // BETA 0.94
MMED // BETA 1.05